Amyloidosis and cardiac involvement

Annales de Medecine Interne

Volumn 151, Issue 8, 2000, Pages 611-617

  Cacoub, Patrice ^a,b,c   Axler, Olivier ^a,b,c   De Zuttere, Dominique ^a,b,c   Hausfater, Pierre ^a,b,c   Amoura, Zahir ^a,b,c   Walter, Sabine ^a,b,c   Wechsler, Bertrand ^a,b,c   Godeau, Pierre ^a,b,c   Piette, Jean Charles ^a,b,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

Amyloid heart disease; Cardiomyopathy; Echocardiography; Systemic amyloidosis

Indexed keywords

AMYLOID; POLYSACCHARIDE;

ADULT; AMYLOIDOSIS; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; MALE; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE;

AMYLOIDOSIS; CARDIOMYOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0034495104     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Amyloidosis
2. The Systemic amyloidoses
3. Restrictive cardiomyopathy
4. Dose intensive melphalan with blood stem cell suport for the treatment of AL amyloidoses
5. AL amyloidosis responds to high dose melphalan and blood stem cells
6. A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, melphalan, prednisone and colchicine
7. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
8. Echocardiographic measurements in normal subjects: Evaluation of an adult population without clinically apparent heart disease
9. Echocardiographic findings in systemic amyloidosis: Spectrum of cardiac involvement and relation to survival
10. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiography and electrocardio-graphic findings in 30 patients with AA and 24 patients with AL amyloidosis
11. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis
12. Doppler echocardiographic measurement of mitral flow volume: Validation of a new method in adult patient
13. Amyloidosis and acquired factor X deficiency treatment with vinca-loaded platelets
14. Survival of patients with primary (AL) amyloidosis, colchicine-treated patients cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973)
15. Treatment of AL amyloidosis with melphalan, prednisone, and colchicine
16. Amyloidosis in multiple myeloma or without apparent cause
17. Demonstration of restrictive ventricular physiology by Doppler echocardiography
18. Amyloidosis (AL): Clinical and laboratory features in 229 cases
19. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases
20. Response rates and survival in primary systemic amyloidosis
21. Cardiac amyloidosis causing cardiac dysfonction: Analysis of 54 necropsy patients
22. Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis
23. Secondary systemic amyloidosis: Response and survival in 64 patients
24. Echocardiographic assessment of the evolution of amyloid heart disease: A study with familial amyloid polyneuropathy
25. DMSO and colchicine therapy in amyloid disease
26. Colchicine in the prevention and treatment of the amyloidosis of familial mediterranean fever
27. Primary systemic amyloidosis: A diagnosis primer
28. Sensitivity and specificity of the echo cardiographic features of cardiac amyloidosis
29. Gertz MA, Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study
30. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvment
31. Endomyocardial biopsy: A review of the literature
32. Closed chest myocardial biopsies: Clinical uses and related problems